By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Developing a unique class of chemically synthesized medicines based on its proprietary platform72.59M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United Kingdom72.59M100.00%